Literature DB >> 19451908

Priority review vouchers: an inefficient and dangerous way to promote neglected-disease drug development.

A S Kesselheim1.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19451908     DOI: 10.1038/clpt.2009.50

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  2 in total

1.  New regulatory paradigms for innovative drugs to treat pediatric diseases.

Authors:  Thomas J Hwang; Florence T Bourgeois
Journal:  JAMA Pediatr       Date:  2014-10       Impact factor: 16.193

2.  Priorities for the Priority Review Voucher.

Authors:  David B Ridley
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.